Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
Yu ZW, Zhong LP, Ji T, Zhang P, Chen WT, Zhang CP. Yu ZW, et al. Oral Oncol. 2010 Apr;46(4):317-22. doi: 10.1016/j.oraloncology.2010.02.002. Epub 2010 Mar 9. Oral Oncol. 2010. PMID: 20219416
MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.
Li J, Huang H, Sun L, Yang M, Pan C, Chen W, Wu D, Lin Z, Zeng C, Yao Y, Zhang P, Song E. Li J, et al. Clin Cancer Res. 2009 Jun 15;15(12):3998-4008. doi: 10.1158/1078-0432.CCR-08-3053. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509158 Free article.
Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue.
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. Wong TS, et al. Clin Cancer Res. 2008 May 1;14(9):2588-92. doi: 10.1158/1078-0432.CCR-07-0666. Clin Cancer Res. 2008. PMID: 18451220 Free article.
Feedback